MCS
The Marcus Corporation
MCS's fundamentals are strong: its operating margin rose 3 points to 4.9% and free cash flow grew more than tenfold. At 34x earnings, it's trading below its usual 42x. Analysts expect strong earnings growth, though they disagree widely on how much.
MCS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
MCS's revenue, profitability, cash flow and balance sheet are all currently healthy.
MCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 31x | $27.22 | — |
| Cheap | 32x | $24.94 | -8.4% |
| Current | 34x | $27.22 | — |
| Fair | 42x | $33.12 | +22% |
| Expensive | 429x | $339 | +1145% |
Historical ranges are pointers, not guarantees.
MCS's PE is in its cheap range at 34x. If earnings grow as analysts expect, today's price would be 31x next year's earnings.
MCS Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Low |
Analysts expect MCS's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.87 | +10% |
| Q3 2026 | $0.79 | +216% |
| Q2 2026 | $0.71 | +54% |
| Q1 2026 | $0.44 | +$0.84 |
| Q4 2025 | $0.41 | +$0.65 |
| Q3 2025 | $0.25 | +$0.49 |
| Q2 2025 | $0.46 | +$1.13 |
| Q1 2025 | -$0.40 | -238% |
| Q4 2024 | -$0.24 | -167% |
MCS's earnings per share have fallen from their peak: $0.79 over the past year, against $1.35 in late 2019.
MCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $237.8M | +13% |
| Q2 2026 | $231.7M | +12% |
| Q1 2026 | $154.4M | +3.8% |
| Q4 2025 | $193.5M | +2.8% |
| Q3 2025 | $210.2M | -9.7% |
| Q2 2025 | $206M | +17% |
| Q1 2025 | $148.8M | +7.4% |
| Q4 2024 | $188.3M | +17% |
MCS's revenue has grown year over year for four quarters in a row: $238M last quarter, up 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 13% | +1.9 points |
| Q2 2026 | 12% | +5.4 points |
| Q1 2026 | -12% | +1.3 points |
| Q4 2025 | 0.9% | +2.1 points |
| Q3 2025 | 11% | -3.3 points |
| Q2 2025 | 6.3% | +5 points |
| Q1 2025 | -14% | -1.7 points |
| Q4 2024 | -1.2% | -1.9 points |
MCS's operating margin was 13% last quarter, up 1.9 points from the same quarter a year ago, near the top of its range since 2019.
MCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $28.4M | +56% |
| Q2 2026 | $44M | +198% |
| Q1 2026 | -$21.9M | +$36.5M |
| Q4 2025 | $26.4M | -2.7% |
| Q3 2025 | $18.2M | +51% |
| Q2 2025 | $14.7M | -8.7% |
| Q1 2025 | -$58.3M | -$27.8M |
| Q4 2024 | $27.1M | +29% |
MCS generated $77M in free cash flow over the past year, more than ten times what it generated the year before.
MCS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.5% | +455K shares |
| 1 year | +1.1% | +329K shares |
| 3 years | -23% | -9.5M shares |
| 5 years | +0.3% | +100K shares |
| Available history | +1.1% | +352K shares |
MCS has 32M diluted shares, up 1.1% from a year ago.
MCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.8x | Very low |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.8x | Healthy |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 1.4x | Healthy |
MCS's net debt is less than a year of its operating earnings (EBITDA), down from 1.9 years a year ago.
MCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.6 | Neutral |
| Stochastic | 21.4 | Neutral |
MCS's weekly RSI is 59 (neutral) and its Stochastic is 21 (neutral).
MCS PE vs Communication Services Sector
| Metric | MCS | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 16x | 109% above |
| PE % | 23 | 26 | 3 pts below |
MCS is trading at 34x earnings, a 109% premium to the Communication Services sector's median of 16x.
MCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 0.4% below |
| 20 week MA | $27.1 | 0.6% above |
| 50 week MA | $21.3 | 28% above |
| 100 week MA | $19.2 | 42% above |
| 200 week MA | $17.1 | 59% above |
MCS's trend is up, with a small recent dip: it's below only its 8-week average, and 59% above its 200-week average.
MCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $12.5 | -61% |
| 2021 | $12.5 | $17.9 | +44% |
| 2022 | $17.9 | $13.9 | -22% |
| 2023 | $13.9 | $14.6 | +4.8% |
| 2024 | $14.6 | $21.4 | +47% |
| 2025 | $21.4 | $15.4 | -28% |
| 2026 YTD | $15.4 | $27.2 | +77% |
MCS is up 77% so far in 2026, after finishing lower in three of the previous six years.